- All resolutions voted with a large majority according to Board of Directors recommendations
- Company renamed Phaxiam Therapeutics, creating a world leader in phage therapy
ERYTECH Pharma (Euronext Paris & Nasdaq: ERYP) announced today that all resolutions for which the Board of Directors recommended a vote in favor, including the approval of the merger with Pherecydes, were adopted by its shareholders at the Combined General Meeting that was held today, June 23, 2023